Patents by Inventor Ingvil Gausemel

Ingvil Gausemel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10941124
    Abstract: The present invention provides methods for the preparation of compounds useful in in vivo therapeutic and diagnostic applications. In particular, the present invention provides a method for the synthesis of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and also methods for the preparation of metal chelates of DOTA.
    Type: Grant
    Filed: December 19, 2016
    Date of Patent: March 9, 2021
    Assignee: GE HEALTHCARE AS
    Inventors: Andreas Richard Meijer, Arne Wang Aabye, Khalid Hussain, Sondre Nilsen, Mikkel Jacob Thaning, Jarle Andre Haugan, Ingvil Gausemel, Nikolai Enes, Silalahi Sumihar
  • Patent number: 10758887
    Abstract: The present invention relates to calibration and normalization systems and methods for ensuring the quality of radiopharmaceuticals during the synthesis thereof, such as radiopharmaceuticals used in Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT).
    Type: Grant
    Filed: July 23, 2018
    Date of Patent: September 1, 2020
    Assignee: GE HEALTHCARE LIMITED
    Inventors: Torgrim Engell, Julian Grigg, Ingvil Gausemel, Knut Dyrstad, Jonathan R. Shales
  • Publication number: 20190001296
    Abstract: The present invention relates to calibration and normalization systems and methods for ensuring the quality of radiopharmaceuticals during the synthesis thereof, such as radiopharmaceuticals used in Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT).
    Type: Application
    Filed: July 23, 2018
    Publication date: January 3, 2019
    Inventors: Torgrim Engell, Julian Grigg, Ingvil Gausemel, Knut Dyrstad, Jonathan R. Shales
  • Publication number: 20180370925
    Abstract: The present invention provides methods for the preparation of compounds useful in in vivo therapeutic and diagnostic applications. In particular, the present invention provides a method for the synthesis of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and also methods for the preparation of metal chelates of DOTA.
    Type: Application
    Filed: December 19, 2016
    Publication date: December 27, 2018
    Applicant: GE Healthcare AS
    Inventors: Andreas Richard Meijer, Arne Wang Aabye, Khalid Hussain, Sondre Nilsen, Mikkel Jacob Thaning, Jarle Andre Haugan, Ingvil Gausemel, Nikolai Enes, Silalahi Sumihar
  • Patent number: 10029228
    Abstract: The present invention relates to calibration and normalization systems and methods for ensuring the quality of radiopharmaceuticals during the synthesis thereof, such as radiopharmaceuticals used in Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT).
    Type: Grant
    Filed: September 24, 2012
    Date of Patent: July 24, 2018
    Assignee: GE Healthcare Limited
    Inventors: Torgrim Engell, Julian Grigg, Ingvil Gausemel, Knut Dyrstad, Jonathan R. Shales
  • Publication number: 20140257566
    Abstract: The present invention relates to calibration and normalization systems and methods for ensuring the quality of radiopharmaceuticals during the synthesis thereof, such as radiopharmaceuticals used in Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT).
    Type: Application
    Filed: September 24, 2012
    Publication date: September 11, 2014
    Inventors: Torgrim Engell, Julian Grigg, Ingvil Gausemel, Knut Dyrstad, Jonathan R. Shales